Clinical Trials Browser

Phase 3 × Carcinoma, Hepatocellular × toripalimab × Clear all

NCT06201065 2024-01-11

FOLFOX-HAIC Plus Lenvatinib and Toripalimab vs. FOLFOX-HAIC Plus Lenvatinib for Advanced Hepatocellular Carcinoma: a Randomized Controlled and Double-blind Trial

Phase 3 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT05056337 2021-09-24

Toripalimab in Combination With Lenvatinib and TACE for Conversion Therapy in Patients With Potentially Resectable HCC

Phase 3 Unknown

Gastrointestinal

Carcinoma, Hepatocellular